Cincinnati.com: UC joins national COVID impact study; you could be recruited for it
UC expert provides details on COMPASS study
Maggie Powers-Fletcher, PhD, of the Division of Infectious Diseases at the UC College of Medicine, was interviewed by Cincinnati.com about the COMPASS study she is leading. The study is part of the efforts by the COVID-19 Prevention Network launched by the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health. It will examine the impact of COVID-19 on communities across the United States.
Maggie Powers-Fletcher, PhD, of the Division of Infectious Diseases at the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand
When the study is ready for enrollment, residents who happen to be in several pre-selected locations, or "pop-up sites" in public spaces around Cincinnati, will be recruited. The sites and recruitment efforts won't be announced in advance, so as not to taint the integrity of the study.
"I think it’s so cool that Cincinnati is involved and there’s no one else in our region that is doing this. This helps put Cincinnati on the map," Powers-Fletcher said. "This gives our community a voice in the larger federal government response of how we’re approaching solutions and approaching research related to this pandemic.”
Read the entire story here. See more coverage of the story from WLWT, WVXU and the Cincinnati Business Courier. Read more about the COMPASS study here.
Lead photo/Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.